Enhertu Plus Perjeta: New First-Line Treatment for Metastatic HER2-Positive Breast Cancer?
moderators
Posts: 9,647
Enhertu Plus Perjeta: New First-Line Treatment for Metastatic HER2-Positive Breast Cancer?
Jun 1, 2025
The combination offered better outcomes than the THP chemo regimen. Read more…
Tagged:
0
Comments
-
So happy this will be replacing THP. My onc. just switched me to this as I had a bad reaction to Taxol during my 2nd infusion. I start in 2 weeks.
To have access to a superior treatment that doesn't involve chemo is huge.
Stage IV mBC to lungs and adrenal gland. HR negative, HER2 positive, Grade 3.
1
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.